Abstract:AIM: To observe the CO inhalation and CO intraperitoneal injection, the protective effects of exogenous CO on the damaged intestine induced by lipopolysaccharide (LPS), and to explore the relationship of protective effect with production of free radical and proinflammatory cytokine platelet activating factor. METHODS: The experiment was performed at the Laboratory of Animal Experimental Center, Nanjing Medical University from March to August 2005. Totally 96 healthy male SD rats were selected. LPS rat models with damaged intestinal tract by LPS intravenous injection were divided into 6 groups randomly: control group with 6 rats and 18 rats in each group. Control group (intravenous injection with equivalent saline), LPS group (intravenous injection LPS, 5 mg/kg), CO inhalation group (2.5×10-4 CO inhalation), CO intraperitoneal injection group (2 mL/kg CO intraperitoneal injection), LPS injection (intravenous injection LPS, 5 mg/kg) plus CO inhalation (2.5×10-4) group and LPS injection (intravenous injection LPS, 5 mg/kg) plus CO intraperitoneal injection (2 mL/kg CO intraperitoneal injection) group were observed at hours 1, 3 and 6 time points in each group. Intestinal malondialdehyde (MDA) content was determined with thiobarbitric acid method. Myeloperoxidase (MPO) activity was determined with chromatometry method. Change of platelet activating factor (PAF) was detected with sandwich enzyme linked immunosorbent assay (ELISA).RESULTS: A total of 96 rats were involved in the result analysis. ①content of intestinal MDA in experimental rats: After LPS administration, rat intestinal MDA increased at hours 1, 3 and 6 time points as compared with the control group. It decreased at hours 3 and 6 in the LPS injection plus CO inhalation group as compared with the LPS group; It decreased at hours 1 and 3 in the LPS injection plus CO intraperitoneal injection group as compared with the LPS group [(0.614±0.057) nmol/g in the control group, (1.443±0.255),(2.747±0.385),(4.023±0.762) nmol/g in the LPS group at hours 1, 3 and 6 time points,(1.172±0.328),(1.740±0.174),(3.417±0.556) nmol/g in the LPS injection plus CO inhalation group, (0.918±0.177),(1.857±0.320),(3.581±0.606) nmol/g in the LPS injection plus CO intraperitoneal injection group,P < 0.05 or 0.01]. ②MPO activity: MPO activity decreased in the LPS injection plus CO inhalation group as compared with the LPS group at hours 3 and 6; It reduced obviously in the LPS injection plus CO intraperitoneal injection group as compared with the LPS group at hours 1, 3 and 6 [At hours 1, 3 and 6(39.875±4.551),(68.080±18.670),(80.333±16.187) nkat/g in the LPS group,(31.823±5.018),(52.077±14.653),(67.730±8.918) nkat/g in the LPS injectionplus CO inhalation group,(29.839±4.801),(51.577 ±12.386),(69.814±10.669) nkat/g in the LPS injection plus CO intraperitoneal injection group,P < 0.05 or 0.01]. ③PAF content: At hours 1, 3 and 6 it increased in the LPS group as compared with the control group; It decreased in the LPS injection plus CO inhalation group as compared with the LPS group at hour 3 and 6; It reduced in the LPS injection plus CO intraperitoneal injection group as compared with the LPS group at hours 1, 3 and 6 [(0.432±0.079) ng/g in the control group, at hours 1, 3 and 6(0.612±0.013),(1.103±0.208),(1.466±0.135) ng/g in the LPS group,(0.565±0.031),(0.878±0.181),(1.308±0.087) ng/g in the LPS injection plus CO inhalation group,(0.499±0.021),(0.772±0.074),(1.433±0.073) ng/g in the LPS injection plus CO intraperitoneal injection group,P < 0.05 or 0.01]. ④arterial blood COHb change: 2.5×10-4 CO inhalation and 2 mL/kg CO intraperitoneal injection could increase COHb, but did not exceed the 10% safe range. ⑤comparison of the two methods: CO intraperitoneal injection produced a marked effect on rat intestine earlier than that CO inhalation did, but the effect of CO inhalation lasted longer. CONCLUSION: Low concentration CO inhalation and low dose CO intraperitoneal injection have a protective effect on rat intestine attacked by LPS. CO protects the rat intestine against LPS by the way of inhibiting expression of PAF and increasing MPO activity, and CO increases rat intestine antioxidation ability. CO intraperitoneal injection and CO inhalation have the same protective effect on rat intestine, but CO intraperitoneal has an earlier effect while CO inhalation has a longer effect.

Carbon Monoxide Attenuates Dextran Sulfate Sodium-Induced Colitis Via Inhibition Of Gsk-3 Beta Signaling

Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway

Exogenous Carbon Monoxide Suppresses Escherichia Coli Vitality and Improves Survival in an Escherichia Coli-Induced Murine Sepsis Model.

Isosteviol Attenuates DSS-induced Colitis by Maintaining Intestinal Barrier Function Through PDK1/AKT/NF-κB Signaling Pathway

Chitosan Oligosaccharides Alleviate Colitis by Regulating Intestinal Microbiota and PPARγ/SIRT1-Mediated NF-κB Pathway

Polyphenolic Extracts of Coffee Cherry Husks Alleviated Colitis-Induced Neural Inflammation Via NF-κB Signaling Regulation and Gut Microbiota Modification.

Didymin Ameliorates Dextran Sulfate Sodium (DSS)-Induced Ulcerative Colitis by Regulating Gut Microbiota and Amino Acid Metabolism in Mice

Mechanism of carbon monoxide protects rat intestine against LPS

Galactooligosaccharides Protects Against DSS-induced Murine Colitis Through Regulating Intestinal Flora and Inhibiting NF-κB Pathway.

Carbon Monoxide-Based Therapy Ameliorates Acute Pancreatitis Via TLR4 Inhibition.

Alpha-Ketoglutarate Attenuates Colitis in Mice by Increasing Lactobacillus Abundance and Regulating Stem Cell Proliferation Via Wnt-Hippo Signaling

Effect of the Combination of Clostridium butyricum and Mycelium of Phellinus igniarius on Intestinal Microbiota and Serum Metabolites in DSS-Induced Colitis

Inhibition of Phosphoinositide 3-Kinase Ameliorates Dextran Sodium Sulfate-Induced Colitis in Mice

Carbon Monoxide Being Hydrogen Sulfide and Nitric Oxide Molecular Sibling, as Endogenous and Exogenous Modulator of Oxidative Stress and Antioxidative Mechanisms in the Digestive System

Hydroxyproline Attenuates Dextran Sulfate Sodium‐Induced Colitis in Mice: Involvment of the NF‐κB Signaling and Oxidative Stress

Low-concentration carbon monoxide protects against lipopolysaccharide-induced rat small intestine injury

Carbon Monoxide Impairs CD11b+Ly-6Chi Monocyte Migration from the Blood to Inflamed Pancreas Via Inhibition of the CCL2/CCR2 Axis.

An Orally-Administered Nanotherapeutics with Carbon Monoxide Supplying for Inflammatory Bowel Disease Therapy by Scavenging Oxidative Stress and Restoring Gut Immune Homeostasis.

Heme Oxygenase-1 Ameliorates Dextran Sulfate Sodium-induced Acute Murine Colitis by Regulating Th17/Treg Cell Balance

Protective effects of exogenous carbon monoxide on the lipopolysaccharide induced intestinal damage of rats

Curcumin as a Potential Therapeutic Agent for Mitigating Carbon Monoxide Poisoning: Evidence from an Experimental Rat Study